Fluvoxamine improved cognitive impairments in a patient with schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 7, 2010, Pages 1345-1346

  Niitsu, Tomihisa ^a   Shirayama, Yukihiko ^a   Fujisaki, Mihisa ^a   Hashimoto, Kenji ^b   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; RISPERIDONE;

ADD ON THERAPY; ADULT; ATTENTION DISTURBANCE; AUDITORY HALLUCINATION; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; INSOMNIA; INTELLIGENCE QUOTIENT; LETTER; MAINTENANCE THERAPY; MEMORY DISORDER; NEUROPSYCHOLOGY; PSYCHOSOCIAL WITHDRAWAL; SCHIZOPHRENIA; SPEECH DISORDER; STUPOR; THOUGHT DISORDER;

COGNITION DISORDERS; FEMALE; FLUVOXAMINE; HUMANS; SCHIZOPHRENIA; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 77956449698     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.06.007     Document Type: Letter

References (5)

1. Hashimoto K. Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship. Cent Nerv Syst Agents Med Chem 2009, 9:197-204.
2. Hashimoto K., Fujita Y., Iyo M. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors. Neuropsychopharmacology 2007, 32:514-521.
3. Iyo M., Shirayama Y., Watanabe H., Fujisaki M., Miyatake R., Fukami G., et al. Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1072-1073.
4. Mummery C.J., Patterson K., Hodges J.R., Wise R.J. Generating 'tiger' as an animal name or a word beginning with T: differences in brain activation. Proc Biol Sci 1996, 263:989-995.
5. Silver H., Aharon N., Kaplan A. Add-on fluvoxamine improves primary negative symptoms: evidence for specificity from response analysis of individual symptoms. Schizophr Bull 2003, 29:541-546.